Medicines in the SGLT2 Inhibitor Class Protect Hearts and Kidneys of People with Diabetes

This meta-analysis provides significant reassurance regarding the cardiovascular and long-term noncardiovascular safety of SGLT2 inhibitors.

Source: SGLT2 Inhibitors Show High Cardiovascular- and Renal-Protective Effects in T2D

About the Author

Your Name and Title Here!

Use your biography to describe your talent and link to your NutriScape Nutrition Profile. From there, you can provide your contact information and link to website and your Social Media Accounts.

Tags: ,

Related Posts

Write for NutriScape!